179 related articles for article (PubMed ID: 26508782)
21. ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
Calpe E; Codony C; Baptista MJ; Abrisqueta P; Carpio C; Purroy N; Bosch F; Crespo M
Blood; 2011 Oct; 118(16):4401-10. PubMed ID: 21865343
[TBL] [Abstract][Full Text] [Related]
22. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
Boelens J; Lust S; Van Bockstaele F; Van Gele M; Janssens A; Derycke L; Vanhoecke B; Philippé J; Bracke M; Offner F
Leuk Res; 2009 Oct; 33(10):1335-43. PubMed ID: 19297020
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
24. BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.
Schleiss C; Ilias W; Tahar O; Güler Y; Miguet L; Mayeur-Rousse C; Mauvieux L; Fornecker LM; Toussaint E; Herbrecht R; Bertrand F; Maumy-Bertrand M; Martin T; Fournel S; Georgel P; Bahram S; Vallat L
Sci Rep; 2019 Jan; 9(1):701. PubMed ID: 30679590
[TBL] [Abstract][Full Text] [Related]
25. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases.
Mortarino M; Gelain ME; Gioia G; Ciusani E; Bazzocchi C; Comazzi S
Vet Immunol Immunopathol; 2009 Apr; 128(4):395-401. PubMed ID: 19144411
[TBL] [Abstract][Full Text] [Related]
26. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
27. Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Haseeb M; Anwar MA; Choi S
Front Immunol; 2018; 9():2720. PubMed ID: 30542344
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
29. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor-induced phosphorylation of the zeta chain is efficiently promoted by ZAP-70 but not Syk.
Steinberg M; Adjali O; Swainson L; Merida P; Di Bartolo V; Pelletier L; Taylor N; Noraz N
Blood; 2004 Aug; 104(3):760-7. PubMed ID: 15059847
[TBL] [Abstract][Full Text] [Related]
31. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
32. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
33. Innate immune signaling in CLL.
Maus MV
Blood; 2016 Jan; 127(4):376-8. PubMed ID: 26823508
[TBL] [Abstract][Full Text] [Related]
34. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
Kawauchi K; Ogasawara T; Yasuyama M
Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
Scupoli MT; Pizzolo G
Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
[TBL] [Abstract][Full Text] [Related]
36. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
Robak T; Robak P
Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
[TBL] [Abstract][Full Text] [Related]
37. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
[TBL] [Abstract][Full Text] [Related]
38. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
[TBL] [Abstract][Full Text] [Related]
40. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
